Drug intelligence / Profile preview

chlorthalidone + losartan

Development stage
Unknown
Lead developer
Laboratorios Silanes
Modality
Small Molecules
Administration
Oral
01

Overview

Chlorthalidone + losartan is a fixed-dose combination of two antihypertensive agents used primarily for the treatment of high blood pressure (hypertension). Chlorthalidone is a thiazide-like diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, promoting diuresis and reducing blood volume. Losartan is an angiotensin II receptor blocker (ARB) that selectively antagonizes the angiotensin II type 1 receptor, leading to vasodilation and reduced aldosterone-mediated sodium retention. Together, these agents lower blood pressure more effectively than either alone, reduce cardiovascular risk (including stroke), and help protect kidney function in patients with diabetes or impaired renal function[1][3][5]. The combination is available as oral tablets.

Brand names
BilosarLosanorm-CHLosium CTLosar-CHCovance CTPlelos ClpFlolex CFelow CZione DSLLosawell C
Other names
losartan + chlorthalidone
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on chlorthalidone + losartan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorthalidone + losartan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call